Survival and safety evaluation of Bifidobacterium longum subsp. longum ZS-8 in healthy adults, determined using PMAxx-qPCR and amplicon sequencing.
- 2025-11-04
- Clinical Trial
- Microbiology spectrum 13(11)
- Feng Liu
- Biao Dong
- Zhongsun Wang
- Dan Lin
- Huan Xu
- Baisheng Ke
- Wanying Kang
- Yang Jin
- Xiuting Huang
- Hui Lu
- Liqing Zhao
- Yun Qian
- Liangling Cai
- Long Xu
- Zhenjiang Zech Xu
- PubMed: 40981476
- DOI: 10.1128/spectrum.02861-24
- Moderate evidence
highlights the safety of ZS-8 oral administration in healthy individuals
- Effect
- Beneficial
- Effect size
- Moderate